Biotech Values

[zipjet]

>> The "active partnering discussions" would likely achieve apogee at approximately the same date as the expiration of the NVS standstill agreement with MNTA (July 2008; NVS owns 13.5% of MNTA, currently). I find this interesting.

Makes sense to me.

M-118 keeps advancing through the studies. Once NVS is no longer subject to the standstill, they could buy the whole company. So if MNTA has not partnered M118 with another company, NVS can buy the whole company - no more royalties, no sharing the profits and they get M119, other programs and the platform.

ij